A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis
Clinical trial NCT04924296 · UNKNOWN
Trial details
- NCT number
- NCT04924296
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2021-12-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.